Related Experiment Video
Updated: May 26, 2026

Evaluation of Substrate Ubiquitylation by E3 Ubiquitin-ligase in Mammalian Cell Lysates
Published on: May 10, 2022
Vitexin inhibits polyubiquitin synthesis by the ubiquitin-conjugating enzyme E2-25K
Kimberli M Helms1, Randall C Wilson, Ifedayo V Ogungbe
1Department of Chemistry, University of Alabama in Huntsville, Huntsville, AL 35899, USA.
Abstract:
An extract of bark from the tropical rainforest plant Byrsonima crassifolia was screened for inhibition of diubiquitin formation by the human ubiquitin-conjugating enzyme E2-25K. Activity assays with both the full-length enzyme and a truncated, active catalytic UBC domain revealed that the extract contained inhibitory properties. Separation of the extract into individual components and additional screens identified vitexin as the active inhibitor. An IC50 for vitexin was calculated to be approximately 0.5 mM. Molecular modeling simulations were used to predict the mode of inhibition and NMR spectra were used to confirm the binding site of vitexin to E2-25K.
Related Concept Videos
Inhibitors of Viral Protein Synthesis
Drugs that Destabilize Microtubules
Eukaryotic Transcription Inhibitors
Eukaryotic transcription inhibitors usually contain two distinct domains, a DNA...
Regulated Protein Degradation
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Drugs that Stabilize Microtubules
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein.

